- Report
- September 2026
- 181 Pages
Global
From €3343EUR$3,545USD£2,800GBP
€3714EUR$3,939USD£3,111GBP
- Report
- September 2026
- 186 Pages
Global
From €3343EUR$3,545USD£2,800GBP
€3714EUR$3,939USD£3,111GBP
- Report
- September 2026
- 199 Pages
Global
From €3343EUR$3,545USD£2,800GBP
€3714EUR$3,939USD£3,111GBP
- Report
- September 2026
- 190 Pages
Global
From €3343EUR$3,545USD£2,800GBP
€3714EUR$3,939USD£3,111GBP
- Report
- September 2026
- 187 Pages
Global
From €3343EUR$3,545USD£2,800GBP
€3714EUR$3,939USD£3,111GBP
- Report
- September 2026
- 197 Pages
Global
From €3343EUR$3,545USD£2,800GBP
€3714EUR$3,939USD£3,111GBP
- Report
- September 2026
- 188 Pages
Global
From €3343EUR$3,545USD£2,800GBP
€3714EUR$3,939USD£3,111GBP
- Report
- September 2026
- 188 Pages
Global
From €3343EUR$3,545USD£2,800GBP
€3714EUR$3,939USD£3,111GBP
- Report
- September 2026
- 197 Pages
Global
From €3343EUR$3,545USD£2,800GBP
€3714EUR$3,939USD£3,111GBP
- Report
- January 2026
- 199 Pages
Global
From €3343EUR$3,545USD£2,800GBP
€3714EUR$3,939USD£3,111GBP
- Report
- November 2026
- 280 Pages
Global
From €5516EUR$5,850USD£4,621GBP
- Report
- November 2026
- 377 Pages
Global
From €5516EUR$5,850USD£4,621GBP
- Report
- November 2026
- 371 Pages
Global
From €5516EUR$5,850USD£4,621GBP
- Report
- November 2026
- 476 Pages
Global
From €5516EUR$5,850USD£4,621GBP
- Report
- November 2026
- 172 Pages
Global
From €5516EUR$5,850USD£4,621GBP
- Report
- November 2026
- 278 Pages
Global
From €5516EUR$5,850USD£4,621GBP
- Report
- November 2026
- 280 Pages
Global
From €5516EUR$5,850USD£4,621GBP
- Report
- November 2026
- 378 Pages
Global
From €5516EUR$5,850USD£4,621GBP
- Report
- November 2026
- 467 Pages
Global
From €5516EUR$5,850USD£4,621GBP
- Report
- November 2026
- 370 Pages
Global
From €5516EUR$5,850USD£4,621GBP

The Dermatologicals market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin diseases, including acne, psoriasis, eczema, and skin cancer. Dermatologicals are typically administered topically, although some may be taken orally. The market is highly competitive, with a wide range of products available from both generic and branded manufacturers.
The Dermatologicals market is driven by the increasing prevalence of skin diseases, as well as the development of new treatments and technologies. Additionally, the increasing demand for cosmetic treatments has also contributed to the growth of the market.
Some of the major companies in the Dermatologicals market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. Other notable players include Allergan, Galderma, and Sun Pharmaceuticals. Show Less Read more